Skip to search formSkip to main contentSkip to account menu

Sch 34826

Known as: Sch-34826, beta-Alanine, N-(N-(2-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)-2-oxo-1-(phenylmethyl)ethyl)-L-phenylalanyl)- 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (4)

AnalgesicsDioxolanesDipeptidesProtease Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats.
1993
1993
Neutral endopeptidase inhibition attenuates development of hypoxic pulmonary hypertension in rats.
Neutral endopeptidase (NEP) inhibition is thought to blunt hypoxic pulmonary hypertension by reducing atrial natriuretic peptide… 
1992
1992
Effects of acute and chronic blockade of neutral endopeptidase with Sch 34826 on NaCl-sensitive hypertension in spontaneously hypertensive rats.
We have previously demonstrated that dietary NaCl supplementation is associated with increased circulating atrial natriuretic… 
1992
1992
Effects of SCH 34826, a neutral endopeptidase inhibitor, on hypoxic pulmonary vascular remodelling.
1992
1992
The effects of orally active enkephalinase inhibitors on morphine withdrawal syndrome.
Considerable evidence has accumulated to suggest that intracerebroventricular administration of enkephalinase inhibitors, which… 
Review
1991
Review
1991
SCH 34826: an overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator.
Our studies with the prototypical NEP inhibitor SCH 34826 indicate the potential role of this class of compounds in… 
Review
1991
Review
1991
SCH 34826: an overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator.
Our studies with the prototypical NEP inhibitor SCH 34826 indicate the potential role of this class of compounds in… 
1991
1991
The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brain.
1991
1991
Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action.
Inhibition of the enzyme neutral metalloendopeptidase potentiates responses to atrial natriuretic factor and elicits reductions… 
1989
1989
Studies on the effect of SCH-34826 and thiorphan on [Met5]enkephalin levels and release in rat spinal cord.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)